Bausch Health Companies Inc

On February 13, 2025, in accordance with the delegation provided by the Board of Directors (the “Board”) of Bausch Health Companies Inc. (the “Company”), the Talent and Compensation Committee of the Board (the” Committee”) approved a change to the compensation of Thomas J. Appio, the Company’s Chief Executive Officer, based on a review of market data and Mr. Appio’s performance. The Committee increased Mr. Appio’s target annual cash bonus opportunity to 150% of his base salary commencing with the annual incentive program for 2025. Also, on February 13, 2025, the Committee approved changes to the compensation of Mr. Jean-Jacques Charhon, Executive Vice President and Chief Financial Officer, and Ms. Seana Carson, Executive Vice President and General Counsel based on a review of market data and Mr. Charhon’s and Ms. Carson’s performance. The Committee increased Mr. Charhon’s target annual cash bonus opportunity to 75% of his base salary commencing with the annual incentive program for 2025 and increased Ms. Carson’s annual base salary to $650,000 effective March 24, 2025, and her target annual cash bonus opportunity to 75% of her base salary commencing with the annual incentive program for 2025 (which, for Ms. Carson, will be converted into and paid in Canadian dollars).